SO-17 The global POLAR program: Top-line results of placebo-controlled studies of calmangafodipir on top of modified FOLFOX6 to prevent chemotherapy-induced peripheral neuropathy
Qvortrup C, Muro K, Lustberg M, Persson A, Näsström J, Carlsson S, Nagahama F, Pfeiffer P. SO-17 The global POLAR program: Top-line results of placebo-controlled studies of calmangafodipir on top of modified FOLFOX6 to prevent chemotherapy-induced peripheral neuropathy. Annals Of Oncology 2021, 32: s209-s210. DOI: 10.1016/j.annonc.2021.05.041.Peer-Reviewed Original Research